PHARMACYTE BIOTECH, INC. Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount of $38.61 thousand for the 3-month period ending 2021-01-31, per its 10-Q filed 2021-03-12.
Discontinued › Notes
us-gaap:StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount · last filed 2021-03-12
- PHARMACYTE BIOTECH, INC. stock option, down round feature, (increase) decrease in equity, amount for the quarter ending 2021-01-31 was $38.61K, a 54.28% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock option, down round feature, (increase) decrease in equity, amount for the quarter ending 2020-10-31 was $56.06K, a 43.03% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock option, down round feature, (increase) decrease in equity, amount for the quarter ending 2020-07-31 was $72.32K, a 42.75% decline year-over-year.
- PHARMACYTE BIOTECH, INC. stock option, down round feature, (increase) decrease in equity, amount for the quarter ending 2020-01-31 was $84.44K.
| Period end | Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount 3 month | Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount 6 month | Stock Option, Down Round Feature, (Increase) Decrease in Equity, Amount 9 month |
|---|---|---|---|
| 2021-01-31 | $38.61K 10-Q · filed 2021-03-12 | $94.67K derived: sum of 2 quarters · filed 2021-03-12 | $166.98K derived: sum of 3 quarters · filed 2021-03-12 |
| 2020-10-31 | $56.06K 10-Q · filed 2021-03-12 | $128.38K derived: sum of 2 quarters · filed 2021-03-12 | |
| 2020-07-31 | $72.32K 10-Q · filed 2021-03-12 | ||
| 2020-01-31 | $84.44K 10-Q · filed 2021-03-12 | $182.84K derived: sum of 2 quarters · filed 2021-03-12 | $309.17K derived: sum of 3 quarters · filed 2021-03-12 |
| 2019-10-31 | $98.41K 10-Q · filed 2021-03-12 | $224.73K derived: sum of 2 quarters · filed 2021-03-12 | |
| 2019-07-31 | $126.33K 10-Q · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |